Product category:
Laboratory information management system (LIMS)
News Release from: Applied Biosystems
Edited by the Laboratorytalk Editorial
Team on 28 August 2002
Global agreement for drug discovery
software
Combines IT and life science applications to give an 'industrial strength' solution for real time data integration of virtually any life science data source
Applied Biosystems has recently signed an agreement with geneticXchange, a provider of data access and integration solutions for life science, to resell the DiscoveryHub software through the Rapid Integration Solutions (RIS) programme DiscoveryHub software combines IT and life science applications to give an industrial strength software solution for real time data integration of virtually any life science data source
This article was originally published on Laboratorytalk on 2 Oct 2001 at 8.00am (UK)
Related stories
High throughput nucleic acid purification
Applied Biosystems has released the ABI Prism 6100 nucleic acid PrepStation for high throughput purification of RNA and DNA, taking only 30 minutes to isolate total RNA from cells
Cattle DNA typing kit
Applied BioSystems says that complete traceability from farm to supermarket is now a reality, providing a new tool to establish the safety of food products
The software accelerates and enhances the drug discovery process by removing data integration and analysis bottlenecks.
Open SQL middleware architecture works alongside existing IT infrastructures to extend and enhance in-house solutions and it can be easily configured to gain rapid access to life science data.
Lightweight wrappers can be created in less than a day to add external web sources, biochip data, Lims or internal databases.
The software provides real time data access and 'live' SQL queries can be run to join remote sources to internal systems secured behind firewalls.
DiscoveryHub software can also simplify data loading; high throughput wrappers efficiently load GenBank records and other large amounts of data into Oracle and other RDBMS.
Brian Donnelly, CEO of geneticXchange, said: "We are very excited to be collaborating with Applied Biosystems to bring innovative new capabilities to the market that will help solve the data integration challenge and produce an immediate and tangible impact on drug R and D productivity.".
• Applied Biosystems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
